Andre E Minoche Selected Research

polyglutamine

1/2019

De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andre E Minoche Research Topics

Disease

1	Hepatoblastoma 12/2023
1	Retinal Dystrophies 03/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2019
1	Cerebellar Ataxia (Dysmetria) 09/2018
1	Paraplegia (Spastic Paraplegia) 09/2018
1	Dystonia (Limb Dystonia) 09/2018

Drug/Important Bio-Agent (IBA)

1	Circulating Tumor DNAIBA 12/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Retinaldehyde (Retinal)IBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	atrophin-1IBA 01/2019
1	polyglutamineIBA 01/2019
1	Co-Repressor ProteinsIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2018

Therapy/Procedure

1	Precision Medicine 12/2023
1	Therapeutics 03/2022